SCHEMBL7247948

SCHEMBL7247948

CSc1sccc1NS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ALOX12 P18054 1/20 0.51
LMNA P02545 4/20 0.50
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
USP2 O75604 1/20 0.50
NOD2 Q9HC29 1/20 0.50
KEAP1 Q14145 1/20 0.50
NFE2L2 Q16236 1/20 0.50
TDP1 Q9NUW8 2/20 0.48
APEX1 P27695 1/20 0.48
RECQL P46063 1/20 0.48
CASP6 P55212 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673427 0.87 CCR2 (0.52) ALDH1A1MAPTMEN1KMT2AALOX12
SCHEMBL7663530 0.86 ALDH1A1 (0.59) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL7248361 0.83 ALDH1A1 (0.49) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL7664079 0.79 ATM (0.53) ALDH1A1MEN1KMT2ALMNAPOLB
SCHEMBL7248655 0.77 SLC40A1 (0.45) ALDH1A1L3MBTL1TDP1
SCHEMBL30958859 0.76 CYP2C9 (0.56) ALDH1A1MAPTLMNAPOLBL3MBTL1
SCHEMBL1200176 0.75 ACLY (0.64) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL8993697 0.73 ALDH1A1 (0.78) ALDH1A1MAPTMEN1KMT2AALOX12
SCHEMBL1200313 0.72 HPGD (0.80) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL8993799 0.72 ALDH1A1 (0.76) ALDH1A1MAPTMEN1KMT2AALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562840-B1 Non-peptidic inhibitors of proteolytic enzymes such as urokinase 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-05-13 US disclosed
US-6492403-B1 TREATING SYMPTOMS OF ACUTE OR CHRONIC DISORDER MEDIATED BY CLASSICAL PATHWAY OF COMPLEMENT CASCADE; PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-12-10 US disclosed